Please login to the form below

restless legs syndrome

This page shows the latest restless legs syndrome news and features for those working in and with pharma, biotech and healthcare.

EC gives nod to restless leg syndrome drug Targin

Mundipharma's Targin has been granted a licence in the EU for the treatment of restless leg syndrome (RLS). ... It is the first opioid to be granted a licence in the EU for RLS, a neurological disorder characterised by an overwhelming urge to move,

Latest news

UCB names Jean-Christophe Tellier as Doliveux's successor

These include already-marketed drugs such as epilepsy therapy Vimpat (lacosamide) and Neupro (rotigotine) for Parkinson's disease and restless legs syndrome (RLS), which are both growing quickly, as well as
Saatchi & Saatchi create Spanish restless legs syndrome campaign

Uncovering Restless Legs Syndrome (Destapando el Síndrome de Piernas Inquietas) has been developed in partnership with Belgium-headquartered pharma company UCB and includes a website with associated blogs, forums and social ... of Restless Legs Syndrome,
US shortage of GSK’s restless legs syndrome treatment Horizant

FDA blames contract manufacturer delays. Delays at GlaxoSmithKline's (GSK) contract manufacturer have caused a shortage in the US of restless legs syndrome treatment Horizant, according to the FDA. ... It is the latest in a long line of problems for
Product updates from Japan

A flurry of new product approvals and filings in Japan includes drugs for pulmonary arterial hypertension, H pylori gastritis, Parkinson's/restless legs syndrome, breast cancer, carnitine deficiency and sedation during ... dentistry. Otsuka
Eliquis and Ryzodeg feature among Japan's year-end approvals

moderate-to-severe idiopathic restless legs syndrome in adults.

More from news
Approximately 3 fully matching, plus 15 partially matching documents found.

Latest Intelligence

Interview: Georg Toufar, Mundipharma

Treatments successfully brought to market in this way include asthma treatment Flutiform, created by Skye Pharma, and restless legs syndrome treatment Targin.
VIDEO interview: Neil Weir, UCB

epilepsy; and Neupro (rotigotine) for Parkinson's disease and restless legs syndrome.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

XenoPort appoints chief medical officer

Dr Kim has been with the US biopharma company since July 2013, when he joined as VP of medical affair, supporting the marketing of Horizant (gabapentin enacarbil) in restless legs syndrome

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Business Development Director – Health Education: excellent commission

Experienced Medical Writers: Competitive Salary and Benefits

Senior Account Manager: Competitive Salary Offered

Account Manager: Negotiable

Medical Writer: Bonus Scheme, PTO &Private Healthcare

CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...: EXCELLENT DAY RATES AVAILABLE

Account Director: Competitive Salary Offered

Business Director: Competitive Salary Offered

Healthcare Communications Account Directors x 2: Salary TBC

Editorial Manager - MedComms: DOE

Account Executive/ Senior Account Executive: competitive Salary Offfered

Account Manager- Healthcare Advertising: Negotiable

Account Manager / Senior Account Manager: 35, 000-40, 000

Medical (Scientific) Director: £120, 000 benefits

Principal Health Economist - North-West: Negotiable

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Account Director – Healthcare Marketing – Berks: Salary TBC

Associate Director: £75, 000-90, 000

Systematic Reviewer - Oxford: Negotiable

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

SAE – Healthcare PR – Award-Winning Consultancy: Salary TBC

Senior Editorial Assistant – Greater Manchester: DOE

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Account Manager / Account Director: Competative

Subscribe to our email news alerts

PMHub

Add my company

mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

AstraZeneca’s oncology renaissance: Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls: ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...